Visit coronavirus.gov for the latest Coronavirus Disease (COVID-19) updates.

You are here

Evidence-Based Resource Summary

Strength of Evidence: 
4 out of 4
4 out of 4
Year Published: 
2016

Statins to Prevent Cardiovascular Disease: Preventive Medication in Adults Age 76 Years and Older

Description of Resource: 
The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating statin use for the primary prevention of cardiovascular disease events and mortality in adults age 76 years and older without a history of heart attack or stroke. This is an I statement, which means evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.

Evidence-Based Resource Details

help Learn more about EBR criteria
Developed By: 
United States Preventive Services Task Force
Developer Type: 
Federal Government
Healthy People 2020 Topic Area(s): 
Heart Disease and Stroke
Healthy People 2020 Objectives: 
Resource Type: 
Systematic Review
Citation: 
U.S. Preventive Services Task Force. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication [Internet]. 2016 Nov [cited 2017 Sept 8]. Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/statin-use-in-adults-preventive-medication1?ds=1&s=statin